Medicare Enrolled
Dr. Ahsan Shah, M.D.
Hematology · Estero, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Ahsan Shah is a hematology in Estero, FL, with 11 years in practice. Based on federal Medicare data, Dr. Shah performed 226,918 Medicare services across 5,839 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $14,942 from 79 pharmaceutical and/or device companies across 541 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice▲ Top 18% volume in FL$ $14,942 industry payments
Medicare Practice Summary
Medicare Utilization ↗226,918
Medicare services
Top 18% in FL for hematology
5,839
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~20,629 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 53,550 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 34,200 | $43 | $137 |
| Iron sucrose injection (Venofer) | 21,100 | $0 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 20,820 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 15,862 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 15,340 | $1 | $5 |
| Azacitidine chemotherapy injection | 10,635 | $0 | $4 |
| Oxaliplatin chemotherapy injection | 8,648 | $0 | $12 |
| Paclitaxel chemotherapy injection | 7,870 | $0 | $2 |
| Daratumumab injection (Darzalex) | 7,020 | $38 | $110 |
| Denosumab injection (Prolia/Xgeva) | 5,460 | $19 | $51 |
| Complete blood count (CBC) with differential | 3,233 | $8 | $29 |
| Immune globulin infusion (Gammagard) | 3,126 | $35 | $108 |
| Dexamethasone injection (steroid) | 2,998 | $0 | $3 |
| Blood draw (venipuncture) | 2,702 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,840 | $1 | $28 |
| Injection, bortezomib, 0.1 mg | 1,120 | $4 | $113 |
| Office visit, established patient (30-39 min) | 1,041 | $99 | $339 |
| Drug injection, under skin or into muscle | 1,033 | $11 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 896 | $0 | $9 |
| Injection of additional new drug or substance into vein | 667 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 610 | $104 | $378 |
| Injection, leucovorin calcium, per 50 mg | 608 | $3 | $12 |
| Injection, fulvestrant, 25 mg | 510 | $7 | $132 |
| Injection, magnesium sulfate, per 500 mg | 482 | $1 | $2 |
| Injection, fluorouracil, 500 mg | 420 | $2 | $7 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 399 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 364 | $50 | $189 |
| Office visit, established patient, complex (40-54 min) | 333 | $141 | $474 |
| Injection, carboplatin, 50 mg | 318 | $2 | $41 |
| Injection, potassium chloride, per 2 meq | 290 | $0 | $4 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 286 | $18 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 229 | $16 | $56 |
| Office visit, established patient (20-29 min) | 203 | $71 | $239 |
| Hospital follow-up visit, moderate complexity | 200 | $65 | $197 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 199 | $23 | $84 |
| Infusion, normal saline solution , 1000 cc | 183 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 176 | $26 | $156 |
| Injection, zoledronic acid, 1 mg | 172 | $7 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 171 | $1 | $3 |
| Administration of additional new drug or substance into vein, 1 hour or less | 150 | $52 | $178 |
| Infusion into a vein for hydration, each additional hour | 144 | $10 | $42 |
| Administration of chemotherapy into vein, each additional hour | 118 | $23 | $79 |
| Injection of drug or substance into vein | 99 | $29 | $156 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 99 | $58 | $206 |
| Initial hospital admission, high complexity | 88 | $142 | $556 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 82 | $26 | $89 |
| Administration of additional new drug or substance into vein using push technique | 75 | $44 | $170 |
| New patient office visit (45-59 min) | 74 | $130 | $453 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 71 | $136 | $562 |
| Initial hospital admission, moderate complexity | 62 | $107 | $377 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 54 | $3 | $11 |
| Prothrombin time test (blood clotting) | 53 | $4 | $15 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 53 | $135 | $637 |
| Automated urinalysis | 50 | $2 | $8 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 49 | $1 | $7 |
| New patient office visit, complex (60-74 min) | 42 | $175 | $585 |
| Red blood count, automated test | 40 | $4 | $10 |
| Administration of chemotherapy into vein using push technique | 39 | $81 | $303 |
| Injection, alteplase recombinant, 1 mg | 36 | $70 | $218 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 34 | $15 | $56 |
| Drawing of blood for a medical problem | 23 | $77 | $277 |
| New patient office visit (30-44 min) | 21 | $83 | $298 |
| Transitional care management services for problem of high complexity | 17 | $223 | $722 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 16 | $141 | $467 |
| Hospital follow-up visit, low complexity | 15 | $41 | $109 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
25.6% high complexity
70.5% medium
3.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,942
Total received (2018-2024)
Avg $2,135/year across 7 years
Top 34% in FL for hematology
79
Companies
541
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,931 (73.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,437 (16.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,573 (10.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,406
2023$4,477
2022$3,969
2021$1,340
2020$647
2019$80
2018$1,023
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,864
Coherus Biosciences Inc.
$1,088
Janssen Biotech, Inc.
$1,029
Merck Sharp & Dohme LLC
$999
Lilly USA, LLC
$700
Celgene Corporation
$622
Novartis Pharmaceuticals Corporation
$594
E.R. Squibb & Sons, L.L.C.
$567
Incyte Corporation
$509
GENZYME CORPORATION
$408
Gilead Sciences, Inc.
$386
PFIZER INC.
$371
Astellas Pharma US Inc
$327
BeiGene USA, Inc.
$323
Foundation Medicine, Inc.
$290
Boehringer Ingelheim Pharmaceuticals, Inc.
$275
Seagen Inc.
$274
Amgen Inc.
$247
Takeda Pharmaceuticals U.S.A., Inc.
$231
SOBI, INC
$203
Daiichi Sankyo Inc.
$187
Epizyme, Inc.,
$167
Alexion Pharmaceuticals, Inc.
$153
Seattle Genetics, Inc.
$150
Eisai Inc.
$148
ARRAY BIOPHARMA INC
$148
GlaxoSmithKline, LLC.
$148
TAIHO ONCOLOGY, INC.
$146
Genentech USA, Inc.
$146
Acrotech Biopharma LLC
$133
CTI BioPharma Corp.
$125
Regeneron Healthcare Solutions, Inc.
$111
PharmaEssentia USA Corporation
$106
Bayer Healthcare Pharmaceuticals Inc.
$99
Intuitive Surgical, Inc.
$96
Myriad Genetic Laboratories, Inc.
$90
Mirati Therapeutics, Inc.
$75
Intera Oncology, Inc
$69
EISAI INC.
$67
ADC Therapeutics America, Inc.
$61
Merck Sharp & Dohme Corporation
$60
Adaptive Biotechnologies Corporation
$55
ABBVIE INC.
$55
Stemline Therapeutics Inc.
$48
CSL Behring
$44
Alnylam Pharmaceuticals Inc.
$43
EMD Serono, Inc.
$41
TerSera Therapeutics LLC
$40
GE HEALTHCARE
$40
MorphoSys, US Inc.
$40
Pharmacyclics LLC, an AbbVie Company
$39
Emmaus Medical, Inc.
$39
Kyowa Kirin, Inc.
$38
JAZZ PHARMACEUTICALS INC.
$38
Acrotech Biopharma Inc.
$34
Deciphera Pharmaceuticals Inc.
$34
Exelixis Inc.
$33
Sumitomo Pharma America, Inc.
$32
Puma Biotechnology, Inc.
$32
Rigel Pharmaceuticals, Inc.
$32
Sobi, Inc
$28
Genmab U.S., Inc.
$27
ImmunoGen, Inc.
$27
PUMA BIOTECHNOLOGY, INC.
$26
SpringWorks Therapeutics, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$25
G1 Therapeutics, Inc.
$24
AbbVie Inc.
$23
Agios Pharmaceuticals, Inc.
$23
Karyopharm Therapeutics Inc.
$21
Immunomedics, Inc.
$20
Pharmacosmos Therapeutics Inc.
$19
AVEO Pharmaceuticals, Inc.
$18
Taiho Oncology, Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$16
Myovant Sciences Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$14
Dova Pharmaceuticals
$13
Octapharma USA, Inc.
$12
Top 3 companies account for 26.6% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELITEK · ENHERTU · EPKINLY · ERLEADA · Elahere · Endari · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · HYQVIA · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INTERA · Idelvion · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PRECISETUMOR · PROMACTA · PYRUKYND · Padcev · Phesgo · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SOLIRIS · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIVDAK · TUKYSA · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · Venclexta · Vonjo · Vyloy · XALKORI · XGEVA · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $7 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
18
Per 100K population
2.3
County median income
$73,099
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
7.3 mi
7.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shah is a mixed practice specialist, with above-average Medicare volume (top 18% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Shah performed 53,550 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $14,942 from 79 companies across 541 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other hematologys in Estero?
Dr. Shah's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Estero
Browse hematologys in Estero ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Coherus Biosciences Inc. Payments to Doctors
See all physicians who received payments from Coherus Biosciences Inc..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology